Last reviewed · How we verify

NCT05274165

Evaluation of New Fitting Characteristics for Extended Wear Hearing Aid Technology

Completed NA Results posted Last updated 28 June 2023
What this trial tests

NA trial testing Lyric Hearing Aid- Experimental Design in Hearing Loss in 25 participants. Completed in 30 September 2022.

Timeline
29 March 2022
Primary endpoint
9 September 2022
30 September 2022

Quick facts

Lead sponsorSonova AG
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment25
Start date29 March 2022
Primary completion9 September 2022
Estimated completion30 September 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sonova AG — full company profile →

Who can join

Adults 18 to 80, any sex, with Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Trial to Success Rate Primary · Day 30 of study

Percentage of participants who express intent to purchase devices at end of study trial period. No statistical analysis was performed on this outcome measure.

GroupValue95% CI
Group A2
Group B0

Adverse events — posted to ClinicalTrials.gov

Time frame: 30 days. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Group A
Serious: 0/12 (0%)
Deaths: 0/12
Group B
Serious: 0/13 (0%)
Deaths: 0/13
Other adverse events (1 terms — click to expand)

ReactionSystemGroup AGroup B
discomfortEar and labyrinth disorders

Data from ClinicalTrials.gov NCT05274165 adverse events section.

Sponsor's own description

Two groups of hearing aid candidates will be fit with extended wear technology. One group will be fit with the commercially available models, and the other group will be fit with either the commercially available model or a new model with different fitting characteristic. After an appropriate trial period, the success rate of each group will be determined by the desire to purchase devices.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hearing Loss

Currently open trials in the same condition.

Other Sonova AG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05274165.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing